- Home
- CHNR vs CELZ Comparison
CHNR vs CELZ Comparison
Compare CHNR & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHNR | CELZ |
|---|---|---|
| Founded | N/A | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 6.3M |
| IPO Year | 1996 | 2008 |
Fundamental Metrics
Financial Performance| Metric | CHNR | CELZ |
|---|---|---|
| Price | $4.10 | $1.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 768.7K | 21.9K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.45 | $1.50 |
| 52 Week High | $57.47 | $6.25 |
Technical Indicators
Market Signals| Indicator | CHNR | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 50.43 | 59.73 |
| Support Level | $3.31 | $1.74 |
| Resistance Level | $4.25 | $2.30 |
| Average True Range (ATR) | 0.55 | 0.12 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 32.82 | 85.44 |
Price Performance
Historical ComparisonAbout CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.